Product Information

ENOXAPARIN 300 MG/3 ML VIAL is a generic product labeled by Meitheal Pharmaceuticals Inc., priced at $10.2663 per ML under NDC 71288042603. Its NADAC has been published 160 times since Oct 5, 2022.

FDA first approved this application on Jun 14, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENOXAPARIN 300 MG/3 ML VIAL

Enoxaparin Sodium
$10.2663per ML

Strength

300 mg/3mL

NDC

71288042603

Classification

Generic

Dosage Form

INJECTION

Route

INTRAVENOUS; SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

ENOXAPARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA214856

FDA Approved

6/14/2022

TE Code

AB

On Market Since

6/14/2022

Pharmacological Classes

Heparin
Low-Molecular-Weight
Low Molecular Weight Heparin

Price Statistics

The NADAC for ENOXAPARIN 300 MG/3 ML VIAL has been published 160 times since Oct 5, 2022, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$10.2663 per ML
All-time high$13.4280 (Jun 14, 2023)
All-time low$9.8758 (Jun 17, 2026)
52-week high$11.6405
52-week low$9.8758
Median price$11.2990
Average price$11.6131
Largest weekly change-9.1% (Apr 17, 2024)
Weeks tracked160
Tracking sinceOct 5, 2022

Price History

1W

+3.4%

1M

+3.4%

3M

+0.8%

6M

-4.5%

1Y

-9.0%

3Y

-23.5%

5Y

N/A

All

-23.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ENOXAPARIN 300 MG/3 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 300 MG/3 ML VIAL, manufactured by Meitheal Pharmaceuticals Inc., is $10.2663 per ML (NDC 71288042603), effective Aug 19, 2026.

How has the price of ENOXAPARIN 300 MG/3 ML VIAL changed over time?

Over the history we have for it, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has declined 23.5%. It has been tracked across 160 weekly CMS publications since Oct 5, 2022.

What are the highest and lowest recorded NADAC prices for ENOXAPARIN 300 MG/3 ML VIAL?

Since Oct 5, 2022, the NADAC for ENOXAPARIN 300 MG/3 ML VIAL has ranged from a low of $9.8758 (Jun 17, 2026) to a high of $13.4280 (Jun 14, 2023), with a median of $11.2990 per ML.

Are there cheaper alternatives to ENOXAPARIN 300 MG/3 ML VIAL?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENOXAPARIN 300 MG/3 ML VIAL in a comparable dosage form, but none are currently priced below it.

Who manufactures ENOXAPARIN 300 MG/3 ML VIAL?

ENOXAPARIN 300 MG/3 ML VIAL (NDC 71288042603) is labeled by Meitheal Pharmaceuticals Inc., and CMS classifies it as a generic product.